Beneficial bacteria pass on antibiotic resistance genes
Researchers from the Hudson Institute of Medical Research and the Wellcome Sanger Institute have revealed how antimicrobial resistance spreads inside the human gut, with their results published in the journal Nature Communications.
Lead researcher Dr Samuel Forster said resistance occurs when bacteria acquire changes and no longer respond to antibiotics. This makes infections harder to treat and increases the risk of disease spread, severe illness and death.
“Antibiotic resistance is emerging at an alarming level, rendering some bacterial infections untreatable and increasing dependence on last-line antibiotics,” Dr Forster said.
Bacteria can develop resistance either through changes in their genetic sequence or by acquiring resistance genes from other bacteria. But resistance in pathogens is just one side of the story — the beneficial bacteria in our microbiomes also need ways to protect themselves, otherwise they will be destroyed every time we take antibiotics.
“The gut microbiome contains thousands of beneficial bacterial species, each of which may carry antibiotic resistance genes and share these with disease-causing bacteria,” Dr Forster said. Understanding the diversity of resistance in the microbiome and which ones can be spread to pathogens allows scientists to be prepared and take actions to prevent this occurring.
“Our research provides world-first experimental identification of the key mediators of this transfer from the microbiome to pathogens,” added Dr Emily Gulliver, a postdoctoral researcher at the Hudson Institute.
“Of most concern, bacteria carrying these elements were also detected in other body sites including the vagina, skin and nasal cavity, with some also found across diverse environmental samples. This suggests how widespread these elements may be.”
Dr Forster said the study of the human gut microbiome is delivering incredible results, stating, “In this case we are discovering the rules that allow bacteria to share key functions between them and using this knowledge to reduce and prevent potentially deadly infections.
“This work provides a new tool in the toolkit for managing the emerging threat of antimicrobial resistance.”
Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.
A pre-emptive approach to treating leukaemia relapse
The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...
Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...
RNA-targeted therapy shows promise for childhood dementia
Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...
